Oct 26, 2017
Nov 28, 2017
The differential diagnosis, investigation, and staging of lymphomas will be reviewed. The biological spectrum and clinical diversity of NHL will discussed. The differences in the approach and the current standard of care for aggressive versus indolent NHL will be explored as will the role of new emerging therapies.
Pierre Laneuville, MD
Non-Hodgkins’ lymphoma, diffuse large cell lymphoma, follicular lymphoma, CT, PET-CT, chemotherapy, monoclonal antibodies, cell therapy.